Search Results 471-480 of 17160 for treatment resistant depression
The purpose of this study is to evaluate the safety and tolerability of REM-422 in patients with relapsed/refractory acute myeloid leukemia or higher-risk ...
... treatment model. Primary outcomes will be reduction in depression severity and reduction of suicide risk along with duration of response. Sequential ...
Rituximab, Cyclophosphamide, Bortezomib, and Dexamethasone in Treating Patients with Relapsed or Refractory Low-Grade Follicular Lymphoma, Waldenstrom ...
Treatment-resistant depression · Tricyclic antidepressants · Valerian: A safe and effective herbal sleep aid? Vaping during pregnancy · Nicotine addiction ...
Treatment-resistant depression · Tricyclic antidepressants · Tuberculosis · Tumor vs. cyst: What's the difference? Type 1 diabetes · Type 1 diabetes in children ...
CJNJ-67652000 and Prednisone for the Treatment of Men With Metastatic Castration-Resistant Prostate Cancer and SPOP Gene Mutations. Print details. Share ...
Inotuzumab Ozogamicin in Treating Younger Patients With Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia. Rochester, Minn. This phase II ...
Treatment-resistant depression · Tricyclic antidepressants · Undigested food in stool · Migraine aura · MRI · Vitamin B-12 and depression. Show more related ...
Inotuzumab Ozogamicin in Treating Younger Patients With Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia · More about research at Mayo Clinic.
It is used to treat duodenal and gastric ulcers, gastric ulcers caused by NSAID use, erosive esophagitis, and gastroesophageal reflux disease (GERD). GERD is a ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.